CRXA Insider Trading Activity and SEC Form 4 Filings
CRXA insider trading summary
No open-market insider purchases or sales of Corixa Corp (CRXA) have been reported on SEC Form 4 in the past 12 months.
Latest CRXA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 12, 2005 | Glaxosmithkline PLC | 10% Owner | Buy | $253.1M (57,515,477 @ $4.40) |
| Jul 12, 2005 | Smithkline Beecham Corp | 10% Owner | Buy | $253.1M (57,515,477 @ $4.40) |
| Jul 12, 2005 | Glaxosmithkline PLC | 10% Owner | Buy | $6.5M (12,500 @ $517.65) |
| Jul 12, 2005 | Glaxosmithkline PLC | 10% Owner | Buy | $6.5M (37,500 @ $172.01) |
| Jul 12, 2005 | Smithkline Beecham Corp | 10% Owner | Buy | $6.5M (12,500 @ $517.65) |
| Jul 12, 2005 | Smithkline Beecham Corp | 10% Owner | Buy | $6.5M (37,500 @ $172.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.